title: [The treatment research of people with different types of HPV infection in sterile patients].
abstract: OBJECTIVE
  Explore the optimal treatment of infertility patients infected with different types of human papillomavirus (HPV).
  
  
  METHODS
  According to cervical pathology, cervical status and the procreate desire of the infertility patients, the 144 clinic cases of high-risk human papillomavirus infected infertile patients were divided into two gruoups: group with treatment and without treatment. Real-time quantitative fluorescent PCR (RT-PCR) has been employed, follow-up time is 6 months, to detect the HPV-DNA in the crevical exfoliated cells, to observe the negative conversion rate and pregnancy rate, and compare analyzed.
  
  
  RESULTS
  (1) In high-risk HPV infectors, the negative conversion rate of treatment group (56.67%) is higher than those in non-treatment group (50.00%); (2) The pregnancy rate of secondary high-risk HPV non-treatment group (50.00%) is higher than the treatment group. The pregnancy rate of primary high-risk HPV treatment group (31.67%) is higher than the non-treatment group (4.00%). (3) Negative conversion rate increases accordingly, on primary high-risk HPV infected groups with Leep, with single drug and with Leep combined with drug therapy. (4) The negative conversion rate and the pregnancy rate of primary high-risk HPV infected groups with surgical therapy is higher than the groups with drug therapy. Surgical + Drugs is better in the two surgical therapies.
  
  
  CONCLUSIONS
  Infertile patients should be routinely screened for cervical HPV. The primary high-risk cervical HPV infection is the etiology of infertility. Preferably, patients with primary high-risk HPV infection in cervical lesions is treated with Leep combined drugs.
authors.affiliation: Department of Obstetrics and Gynecology, The Third Affiliated hospital of Guangzhou Medical College, China. gzzld@hotmail.com
authors.forename: Li-dong
authors.initials: LD
authors.lastname: Zhang
authors.forename: Jing
authors.initials: J
authors.lastname: Pei
authors.forename: Hui-min
authors.initials: HM
authors.lastname: Zhang
authors.forename: Xiao-fang
authors.initials: XF
authors.lastname: Sun
mesh_terms: D000328:Adult; D004279:DNA, Viral / Q000032:analysis* / Q000187:drug effects; D004358:Drug Therapy; D005260:Female; D006801:Humans; D007246:Infertility / Q000821:virology*; D027383:Papillomaviridae / Q000187:drug effects* / Q000235:genetics; D030361:Papillomavirus Infections / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D004364:Pharmaceutical Preparations; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D018873:Pregnancy Rate; D012307:Risk Factors; D036302:Therapeutic Human Experimentation
chemical_list: D004279:DNA, Viral; D004364:Pharmaceutical Preparations